Payer+Provider's Health System Review
July 3, 2024
This paper is written from the author’s perspective after receiving ATGAM equine immunotherapy for the treatment of aplastic anemia. This journey began in 2017 with the diagnosis of T-cell lymphocytic leukemia without having achieved remission. T…